ArticleClinical pharmacokinetics2020

Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"

Axel Krebs-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.